PMC:7589163 / 93928-94266
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T454","span":{"begin":63,"end":72},"obj":"Disease"},{"id":"T455","span":{"begin":191,"end":200},"obj":"Disease"}],"attributes":[{"id":"A454","pred":"mondo_id","subj":"T454","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A455","pred":"mondo_id","subj":"T455","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double-blind placebo-controlled trial. Srinivasan et al., 2012 [261] Uganda 352 children with severe pneumonia 20 mg if ≥12 months, 10 mg if \u003c12 months, for 7 days No significant effect on time to resolution of symptoms; decreased mortality rate."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T818","span":{"begin":74,"end":75},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double-blind placebo-controlled trial. Srinivasan et al., 2012 [261] Uganda 352 children with severe pneumonia 20 mg if ≥12 months, 10 mg if \u003c12 months, for 7 days No significant effect on time to resolution of symptoms; decreased mortality rate."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T290","span":{"begin":63,"end":72},"obj":"Phenotype"},{"id":"T291","span":{"begin":191,"end":200},"obj":"Phenotype"}],"attributes":[{"id":"A290","pred":"hp_id","subj":"T290","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A291","pred":"hp_id","subj":"T291","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double-blind placebo-controlled trial. Srinivasan et al., 2012 [261] Uganda 352 children with severe pneumonia 20 mg if ≥12 months, 10 mg if \u003c12 months, for 7 days No significant effect on time to resolution of symptoms; decreased mortality rate."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T618","span":{"begin":0,"end":125},"obj":"Sentence"},{"id":"T619","span":{"begin":127,"end":338},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double-blind placebo-controlled trial. Srinivasan et al., 2012 [261] Uganda 352 children with severe pneumonia 20 mg if ≥12 months, 10 mg if \u003c12 months, for 7 days No significant effect on time to resolution of symptoms; decreased mortality rate."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"3758","span":{"begin":170,"end":178},"obj":"Species"},{"id":"3796","span":{"begin":46,"end":72},"obj":"Disease"},{"id":"3797","span":{"begin":191,"end":200},"obj":"Disease"},{"id":"3798","span":{"begin":323,"end":332},"obj":"Disease"}],"attributes":[{"id":"A3758","pred":"tao:has_database_id","subj":"3758","obj":"Tax:9606"},{"id":"A3796","pred":"tao:has_database_id","subj":"3796","obj":"MESH:D045169"},{"id":"A3797","pred":"tao:has_database_id","subj":"3797","obj":"MESH:D011014"},{"id":"A3798","pred":"tao:has_database_id","subj":"3798","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double-blind placebo-controlled trial. Srinivasan et al., 2012 [261] Uganda 352 children with severe pneumonia 20 mg if ≥12 months, 10 mg if \u003c12 months, for 7 days No significant effect on time to resolution of symptoms; decreased mortality rate."}